BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Fatty acid metabolic process
,
Lung cancer
,
Retina
,
Alcohol
,
Lipopolysaccharide
,
MYC
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ldl 1
Summary
General Info
Curated Studies
Most Correlated Studies
Monocytic leukemia and breast carcinoma wildtype or MLX-depleted cells treated with acLDL or glucose
Macrophages treated with oxidized or acetylated low-density lipoprotein and complement protein C1q
Umbilical artery endothelial cells in response to estradiol and oxidized low density lipoprotein
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Impact of oxidized LDL/LOX-1 system on ligamentum flavum hypertrophy.
Association between triglyceride glucose index and adverse clinical outcomes in patients with acute …
Reducing the Damage of Ox-LDL/LOX-1 Pathway to Vascular Endothelial Barrier Can Inhibit Atherosclero…
New LDL target of 1.4: a lot of work and little benefit].
Low IDL-B and high LDL-1 subfraction levels in serum of ALS patients.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Bariatric Surgery and LDL Cholesterol
Early Alirocumab to Reduce LDL-C in Myocardial Infarction
A Phase 1 Study of an Investigational Drug, ALN-PCSSC, in Subjects With Elevated Low Density Lipopro…
Trial to Evaluate Safety and Tolerability of ALN-PCS02 in Subjects With Elevated LDL-Cholesterol (LD…
LDL Cholesterol TARGETs in OLDer Patients (Age≥75 Years) With ASCVD (TARGET OLD)
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ